Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model

The severe course of bloodstream infections with Gram-negative bacilli can lead to organ dysfunctions and compromise the integrity of the vascular barrier, which are the hallmarks of sepsis. This study aimed to investigate the potential effect of cefiderocol on the barrier function of vascular endot...

Full description

Bibliographic Details
Main Authors: Dagmar Hildebrand, Jana Böhringer, Eva Körner, Ute Chiriac, Sandra Förmer, Aline Sähr, Torsten Hoppe-Tichy, Klaus Heeg, Dennis Nurjadi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/5/581
_version_ 1797502035704152064
author Dagmar Hildebrand
Jana Böhringer
Eva Körner
Ute Chiriac
Sandra Förmer
Aline Sähr
Torsten Hoppe-Tichy
Klaus Heeg
Dennis Nurjadi
author_facet Dagmar Hildebrand
Jana Böhringer
Eva Körner
Ute Chiriac
Sandra Förmer
Aline Sähr
Torsten Hoppe-Tichy
Klaus Heeg
Dennis Nurjadi
author_sort Dagmar Hildebrand
collection DOAJ
description The severe course of bloodstream infections with Gram-negative bacilli can lead to organ dysfunctions and compromise the integrity of the vascular barrier, which are the hallmarks of sepsis. This study aimed to investigate the potential effect of cefiderocol on the barrier function of vascular endothelial cells (vECs) in an in vitro experimental set-up. Human umbilical vein cells (HUVECs), co-cultured with erythrocyte-depleted whole blood for up to 48 h, were activated with tumor necrosis factor-alpha (TNF-α) or lipopolysaccharide (LPS) to induce endothelial damage in the absence or presence of cefiderocol (concentrations of 10, 40 and 70 mg/L). The endothelial integrity was quantified using transendothelial electrical resistance (TEER) measurement, performed at 0, 3, 24 and 48 h after stimulation. Stimulation with TNF-α and LPS increased the endothelial permeability assessed by TEER at 24 and 48 h of co-culture. Furthermore, cefiderocol reduces interleukin-6 (IL-6), interleukin-1β (IL-1β) and TNF-α release in peripheral blood mononuclear cells (PBMCs) following LPS stimulation in a dose-dependent manner. Collectively, the data suggest that cefiderocol may have an influence on the cellular immune response and might support the maintenance of vEC integrity during inflammation associated with infection with Gram-negative bacteria, which warrants further investigations.
first_indexed 2024-03-10T03:28:09Z
format Article
id doaj.art-45666f82f8fb495bbc843ac52f7f04c2
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T03:28:09Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-45666f82f8fb495bbc843ac52f7f04c22023-11-23T09:48:06ZengMDPI AGAntibiotics2079-63822022-04-0111558110.3390/antibiotics11050581Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental ModelDagmar Hildebrand0Jana Böhringer1Eva Körner2Ute Chiriac3Sandra Förmer4Aline Sähr5Torsten Hoppe-Tichy6Klaus Heeg7Dennis Nurjadi8Medical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyHospital Pharmacy, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyHospital Pharmacy, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyMedical Microbiology and Hygiene, Department of Infectious Diseases, Heidelberg University Hospital, 69120 Heidelberg, GermanyThe severe course of bloodstream infections with Gram-negative bacilli can lead to organ dysfunctions and compromise the integrity of the vascular barrier, which are the hallmarks of sepsis. This study aimed to investigate the potential effect of cefiderocol on the barrier function of vascular endothelial cells (vECs) in an in vitro experimental set-up. Human umbilical vein cells (HUVECs), co-cultured with erythrocyte-depleted whole blood for up to 48 h, were activated with tumor necrosis factor-alpha (TNF-α) or lipopolysaccharide (LPS) to induce endothelial damage in the absence or presence of cefiderocol (concentrations of 10, 40 and 70 mg/L). The endothelial integrity was quantified using transendothelial electrical resistance (TEER) measurement, performed at 0, 3, 24 and 48 h after stimulation. Stimulation with TNF-α and LPS increased the endothelial permeability assessed by TEER at 24 and 48 h of co-culture. Furthermore, cefiderocol reduces interleukin-6 (IL-6), interleukin-1β (IL-1β) and TNF-α release in peripheral blood mononuclear cells (PBMCs) following LPS stimulation in a dose-dependent manner. Collectively, the data suggest that cefiderocol may have an influence on the cellular immune response and might support the maintenance of vEC integrity during inflammation associated with infection with Gram-negative bacteria, which warrants further investigations.https://www.mdpi.com/2079-6382/11/5/581cefiderocolbeta-lactam antibioticendothelial barriervascular leakage
spellingShingle Dagmar Hildebrand
Jana Böhringer
Eva Körner
Ute Chiriac
Sandra Förmer
Aline Sähr
Torsten Hoppe-Tichy
Klaus Heeg
Dennis Nurjadi
Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
Antibiotics
cefiderocol
beta-lactam antibiotic
endothelial barrier
vascular leakage
title Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
title_full Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
title_fullStr Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
title_full_unstemmed Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
title_short Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
title_sort cefiderocol protects against cytokine and endotoxin induced disruption of vascular endothelial cell integrity in an in vitro experimental model
topic cefiderocol
beta-lactam antibiotic
endothelial barrier
vascular leakage
url https://www.mdpi.com/2079-6382/11/5/581
work_keys_str_mv AT dagmarhildebrand cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT janabohringer cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT evakorner cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT utechiriac cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT sandraformer cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT alinesahr cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT torstenhoppetichy cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT klausheeg cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel
AT dennisnurjadi cefiderocolprotectsagainstcytokineandendotoxininduceddisruptionofvascularendothelialcellintegrityinaninvitroexperimentalmodel